Consensus Guidelines for Diagnosis, Treatment and Follow-up of Patients with Pancreatic Cancer in Spain
Overview
Authors
Affiliations
The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
Liao H, Li Y, Yang Y, Liu H, Zhang J, Liang H Diagnostics (Basel). 2022; 12(8).
PMID: 36010267 PMC: 9406915. DOI: 10.3390/diagnostics12081915.
Koustas E, Trifylli E, Sarantis P, Papadopoulos N, Karapedi E, Aloizos G Int J Mol Sci. 2022; 23(12).
PMID: 35743107 PMC: 9224428. DOI: 10.3390/ijms23126664.
Importance of mutation for the current treatment of pancreatic cancer beyond maintenance.
Martinez-Galan J, Rodriguez I, Caba O World J Gastroenterol. 2021; 27(39):6515-6521.
PMID: 34754149 PMC: 8554401. DOI: 10.3748/wjg.v27.i39.6515.
Systematic appraisal of guidelines for the diagnosis of pancreatic cancer.
Liu X, Yang T, Shi X, Xiao B, An L, Zheng S Gland Surg. 2021; 10(4):1487-1498.
PMID: 33968700 PMC: 8102215. DOI: 10.21037/gs-20-676.
Prieto-Garcia E, Diaz-Garcia C, Agudo-Lopez A, Pardo-Marques V, Garcia-Consuegra I, Asensio-Pena S Biomedicines. 2021; 9(4).
PMID: 33807441 PMC: 8065458. DOI: 10.3390/biomedicines9040364.